(February 11, 2020 / JNS) As fears of the growing coronavirus endemic increase worldwide, Israel’s Sheba Medical Center, Tel Hashomer, has developed a groundbreaking way to treat potential patients without risking the health of hospital staff and other patients.
Using a Vici telemedicine system, designed by virtual health-care company Intouch Health, the robot-like apparatus can be controlled by doctors and nurses to enter the infected patient’s room and even monitor the patient’s vital signs, such as heart rate.
“This is one way to use telemedicine to protect our staff,” said Dr. Galia Barkai, head of Telemedicine Services at Sheba Medical Center. “By minimizing direct contact between the patients and medical personnel, we reduce the percentage risk of health-care staff contracting the virus.”
While coronavirus has not yet spread to Israel, Sheba is also prepared with a number of isolation rooms in case multiple patients are infected at the same time in an effort to protect staff and other patients from risk of infection.
“Although we don’t have any positive patients in Israel, we are always dealing with suspected patients and preparing for the worst-case scenario,” said Barkai. “So, we are creating all these systems to help us deal with the occasion when we might have to deal with many patients.”
Sheba will also use the telemedicine application Datos to help treat coronavirus patients who are not as critically ill. This application allows medical professionals to monitor patients from the comfort and isolation of their own homes.
“We would give them our telemedicine application and communicate with them via video at least twice a day,” she said. “This would allow them to stay more comfortably in their homes and reduce risk within the hospital.”
The Center for Disease Control and Prevention (CDC) is closely monitoring the outbreak of the new coronavirus (2019-nCoV), which first detected in Wuhan City, Hubei Province, China, and that continues to expand. Chinese health officials have reported tens of thousands of infections, with reports of more than 1,000 deaths in mainland China having been caused by the respiratory ailment.
At a news conference in Geneva on Tuesday, Dr. Michael J. Ryan, executive director of the World Health Organization (WHO), said “one clinical trial is already on the way” in China in an attempt to find a cure to the novel coronavirus. He adding that WHO was working with Chinese authorities to implement further clinical trials.
Support Jewish Journalism
with 2020 Vision
JNS is more than just another news website and syndication service. It is an organization devoted to nonstop reporting, and telling the truth about Israel and Jewish issues unburdened by the biases and institutional blinders that distort so much of what we read, hear and see about these topics elsewhere in the secular and even Jewish press.
At JNS, you get the facts about Israel and Jewish issues without the bias that so often tilts the argument against the Jewish state. JNS articles and columns are republished every week by digital outlets and print newspapers across the globe. But in the age of round-the-clock news coverage, advertising and syndication revenues are not enough to support our continued growth. We need your financial help to keep JNS on target as we continue our fair and accurate reporting.
Please help us take JNS to the next level with a tax-deductible sponsorship, either on a recurring monthly basis. Jewish News Syndicate is a 501(c)3 not-for-profit organization.